Stayble Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
Stayble Therapeutics has a total shareholder equity of SEK12.2M and total debt of SEK850.0K, which brings its debt-to-equity ratio to 7%. Its total assets and total liabilities are SEK15.8M and SEK3.6M respectively.
Key information
7.0%
Debt to equity ratio
SEK 850.00k
Debt
| Interest coverage ratio | n/a |
| Cash | SEK 8.06m |
| Equity | SEK 12.22m |
| Total liabilities | SEK 3.56m |
| Total assets | SEK 15.78m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: STABL's short term assets (SEK10.1M) exceed its short term liabilities (SEK2.7M).
Long Term Liabilities: STABL's short term assets (SEK10.1M) exceed its long term liabilities (SEK850.0K).
Debt to Equity History and Analysis
Debt Level: STABL has more cash than its total debt.
Reducing Debt: STABL's debt to equity ratio has reduced from 25.7% to 7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: STABL has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: STABL has less than a year of cash runway if free cash flow continues to reduce at historical rates of 23.7% each year